Shortly after the Trump administration took office, it started canceling grants for things it had disagreements with: funding for pandemic preparation, efforts to diversify the scientific workforce, efforts that targeted minority health issues, and more. These terminations were challenged in court, and a consolidated case was heard in the District of Massachusetts, pitting the government against individual researchers, organizations that represent them, and states that host research institutions.

The result was a decisive win for the scientists. As the ruling explained , the government's termination efforts violated a statute against "arbitrary and capricious" policies, resulting in a stay that both blocked implementation of the policy and restored the flow of research funding.